The Comparison of Guidelines for Management of Dyslipidemia and the Appropriateness of Them in Korea.
10.4082/kjfm.2010.31.3.171
- Author:
Young Gyu CHO
1
;
Hong Ji SONG
;
Byung Ju PARK
Author Information
1. National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea. bjpark@snu.ac.kr
- Publication Type:Review
- Keywords:
Dyslipidemia;
Guideline;
Cardiovascular Disease;
Epidemiology;
Lipid-Lowering Agent;
Statin
- MeSH:
Atherosclerosis;
Cardiovascular Diseases;
Consensus;
Dyslipidemias;
Hydroxymethylglutaryl-CoA Reductase Inhibitors;
Incidence;
Korea;
Risk Factors;
United States
- From:Korean Journal of Family Medicine
2010;31(3):171-181
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
There have been accumulating evidences that dyslipidemia is a major risk factor of cardiovascular disease (CVD) and improvement in lipid profile can reduce the incidence of CVD. Guidelines for management of dyslipidemia have been developed by major organizations in several contries including the United States. In Korea, a guideline was also published by the Korean Society of Lipidology and Atherosclerosis. However, This guideline was not based on evidences in Korea, but was made by a consensus of experts using a pre-developed guideline as a reference. For clinical application for Korean of guidelines developed in different nations, the disease epidemiology and medical environment in Korea should be considered. In this article, we reviewed whether guidelines for management of dyslipidemia are applicable in Korean context.
